While the importance of representing diverse populations in vaccine trials is increasingly recognised, there are still significant improvements to be made regarding clinical trial inclusion. VACCELERATE is a network of research institutes that envisions to streamline vaccine development for COVID-19 and for any future outbreaks, and to improve participation in vaccine trials across European countries.
Through this survey, we aim to identify the barriers to participate in vaccine trials among pregnant and lactating women, children and adolescents, and older adults (over 65 years of age).
Secondary objectives include identifying:
- barriers against access to vaccine research
- barriers to vaccine trial enrollment of selected groups of individuals
- causes of underrepresentation in vaccine trials
- motivators in enrolling to vaccine trial volunteer registry
Who Is This Survey Addressed To?
If you are a professional with expertise or currently working in a field related to vaccine trials and vaccine development for pregnant and lactating women, and/or children and adolescents, and/or older adults (over 65 years of age), with full working proficiency of the English language, you are invited to participate.
The survey consists of a total 20 questions (11 main questions and 9 conditional questions) and will take approximately 10 minutes to complete. Please read the questions thoroughly and answer as honestly as possible. There are no incorrect answers. You do not need to create an account. The questionnaire will be anonymous as no identifiable information will be collected and we will not be able to contact you.
Your participation is voluntary. You may withdraw from the survey at any time by simply closing your browser window. However, if you reach the end of the survey and click the submission button, your answers will be final and you will not be able to withdraw your submission. Your personal data will not be collected, and your submitted answers will be treated anonymously.
If you have any questions or concerns regarding the design or conduct of the survey, please contact us at [email protected].
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 101037867.
Who Are We?
VACCELERATE is an EU-funded project (Grant Agreement no. 101037867) aiming to accelerate phase II & III COVID-19 vaccine clinical trials and help us better prepare for infectious disease outbreaks in the future.
The project is coordinated by the University Hospital of Cologne in Germany and is support by a large multidisciplinary group of expert from 23 different countries, including Austria, Belgium, Cyprus Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Lithuania, Netherlands, Norway, Poland, Portugal, Serbia, Slovakia, Spain, Sweden, Switzerland, and Turkey.
Protection of My Personal Data
Privacy and confidentiality are very important to us.
In the context of this survey data is collected and stored anonymously in our LimeSurvey and SPSS database to be used solely for research purposes. Therefore, your answers cannot be exploited and will not be shared with third parties, and will remain strictly confidential among partners in VACCELERATE and will be stored on password-protected systems.
Your personal data is protected by the General Data Protection Regulation (EU) 2016/679 (including Art. 9 GDPR about processing of special categories of personal data) and the European Directive 2016/680 and National Legislation, for non-EU VACCELERATE partner countries include Israel, Norway, Serbia, Switzerland, and Turkey. The law guarantees the right of access, correction, objection, processing and transferability of your data. In addition, it guarantees you the right to be notified should a breach of your data occur. For more information regarding the GDPR, you may visit GDPR.
You may contact Prof. Murat Akova, M.D. at [email protected] for any further information or exercise of any right.
